首页> 外文OA文献 >Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
【2h】

Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.

机译:氨基糖苷类抗生素对肾脏溶酶体磷脂酶A和C的抑制:氨基糖苷类毒性的可能机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nephrotoxicity is an important side effect of aminoglycoside antibiotics, which are used to control infections caused by Gram-negative bacteria. Accumulation of aminoglycosides and phospholipids in the lysosomes is a prominent and early feature of aminoglycoside nephrotoxicity and is characterized histologically by the presence of numerous multilamellar bodies in kidney proximal tubule cells. Previous studies have shown that the drug-induced phospholipid fatty liver in man and animals is due to concentration of certain cationic amphiphilic drugs in lysosomes with inhibition of lysosomal phospholipases. It seemed possible that this mechanism might also explain the elevated levels of phospholipid and increased numbers of multilamellar bodies reported in the kidney cortex in aminoglycoside nephrotoxicity. In this study, subcellular localization of acid phospholipases A and C has been shown to be lysosomal in rat kidney cortex. A soluble lysosomal protein fraction was isolated and found to contain both phospholipase A and phospholipase C activity. Streptomycin did not inhibit the release of fatty acids from [3H]dioleoylphosphatidylcholine. However, amikacin, dibekacin, gentamicin, and tobramycin inhibited both phospholipase A and phospholipase C. Our results suggest that the accumulation of phospholipids in lysosomes of kidney cortex, an early and pervasive feature of acute aminoglycoside nephrotoxicity, is due to inhibition of lysosomal phospholipases.
机译:肾毒性是氨基糖苷类抗生素的重要副作用,其可用于控制革兰氏阴性细菌引起的感染。溶酶体中氨基糖苷和磷脂的积累是氨基糖苷肾毒性的突出和早期特征,其组织学特征是肾脏近端小管细胞中存在许多多层体。先前的研究表明,人和动物药物诱导的磷脂脂肪肝是由于溶酶体中某些阳离子两亲药物的浓度升高,而溶酶体磷脂酶受到抑制。似乎该机制也可能解释了在氨基糖苷肾毒性中肾皮质中报告的磷脂水平升高和多层体数目增加。在这项研究中,酸性磷脂酶A和C的亚细胞定位已显示在大鼠肾皮质中是溶酶体的。分离出可溶性溶酶体蛋白级分,发现其同时具有磷脂酶A和磷脂酶C活性。链霉素不抑制脂肪酸从[3H]二油酰基磷脂酰胆碱中释放。但是,丁胺卡那霉素,地贝卡星,庆大霉素和妥布霉素同时抑制磷脂酶A和磷脂酶C。

著录项

  • 作者

    Hostetler, K Y; Hall, L B;

  • 作者单位
  • 年度 1982
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号